Cargando…

Retraction: A high-throughput metabolomics strategy for discovering the influence of differential metabolites and metabolic pathways of huaxian capsules on sepsis-associated Qi deficiency and blood stasis syndrome

Retraction of ‘A high-throughput metabolomics strategy for discovering the influence of differential metabolites and metabolic pathways of huaxian capsules on sepsis-associated Qi deficiency and blood stasis syndrome’ by Qun Liang et al., RSC Adv., 2019, 9, 30868–30878, DOI: 10.1039/C9RA06679A....

Descripción completa

Detalles Bibliográficos
Autor principal: Fisher, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133851/
https://www.ncbi.nlm.nih.gov/pubmed/35685909
http://dx.doi.org/10.1039/d1ra90055b
_version_ 1784713664020873216
author Fisher, Laura
author_facet Fisher, Laura
author_sort Fisher, Laura
collection PubMed
description Retraction of ‘A high-throughput metabolomics strategy for discovering the influence of differential metabolites and metabolic pathways of huaxian capsules on sepsis-associated Qi deficiency and blood stasis syndrome’ by Qun Liang et al., RSC Adv., 2019, 9, 30868–30878, DOI: 10.1039/C9RA06679A.
format Online
Article
Text
id pubmed-9133851
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-91338512022-06-08 Retraction: A high-throughput metabolomics strategy for discovering the influence of differential metabolites and metabolic pathways of huaxian capsules on sepsis-associated Qi deficiency and blood stasis syndrome Fisher, Laura RSC Adv Chemistry Retraction of ‘A high-throughput metabolomics strategy for discovering the influence of differential metabolites and metabolic pathways of huaxian capsules on sepsis-associated Qi deficiency and blood stasis syndrome’ by Qun Liang et al., RSC Adv., 2019, 9, 30868–30878, DOI: 10.1039/C9RA06679A. The Royal Society of Chemistry 2021-02-03 /pmc/articles/PMC9133851/ /pubmed/35685909 http://dx.doi.org/10.1039/d1ra90055b Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by/3.0/
spellingShingle Chemistry
Fisher, Laura
Retraction: A high-throughput metabolomics strategy for discovering the influence of differential metabolites and metabolic pathways of huaxian capsules on sepsis-associated Qi deficiency and blood stasis syndrome
title Retraction: A high-throughput metabolomics strategy for discovering the influence of differential metabolites and metabolic pathways of huaxian capsules on sepsis-associated Qi deficiency and blood stasis syndrome
title_full Retraction: A high-throughput metabolomics strategy for discovering the influence of differential metabolites and metabolic pathways of huaxian capsules on sepsis-associated Qi deficiency and blood stasis syndrome
title_fullStr Retraction: A high-throughput metabolomics strategy for discovering the influence of differential metabolites and metabolic pathways of huaxian capsules on sepsis-associated Qi deficiency and blood stasis syndrome
title_full_unstemmed Retraction: A high-throughput metabolomics strategy for discovering the influence of differential metabolites and metabolic pathways of huaxian capsules on sepsis-associated Qi deficiency and blood stasis syndrome
title_short Retraction: A high-throughput metabolomics strategy for discovering the influence of differential metabolites and metabolic pathways of huaxian capsules on sepsis-associated Qi deficiency and blood stasis syndrome
title_sort retraction: a high-throughput metabolomics strategy for discovering the influence of differential metabolites and metabolic pathways of huaxian capsules on sepsis-associated qi deficiency and blood stasis syndrome
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133851/
https://www.ncbi.nlm.nih.gov/pubmed/35685909
http://dx.doi.org/10.1039/d1ra90055b
work_keys_str_mv AT fisherlaura retractionahighthroughputmetabolomicsstrategyfordiscoveringtheinfluenceofdifferentialmetabolitesandmetabolicpathwaysofhuaxiancapsulesonsepsisassociatedqideficiencyandbloodstasissyndrome